Dr. Reddy's Laboratories Ltd. closed 13.36% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Shares of Dr Reddys Laboratories experienced a decline of 0.67% to Rs 1228.00 during today's trading session, accompanied by ...

Dr. Reddy's Laboratories Ltd. closed 13.05% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr Reddys Laboratories shares experienced notable trading activity, with the price currently at Rs 1215.40, reflecting a 0.69 ...

Discover why Dr. Reddy’s Laboratories remains a strong buy amid robust revenue growth, underappreciated pipeline potential, ...

Stay updated with the Dr Reddys Stock Liveblog, your one-stop destination for real-time information and analysis of a leading ...

Shares of Dr. Reddy’s Laboratories are on track to break through a critical range between ₹1,200 and ₹1,220 where surpassing ...

Dr Reddy's Laboratories Ltd (NYSE:RDY) achieved record high revenue exceeding $3.8 billion and crossed the $1 billion threshold in EBITDA for the first time. The company reported a year-over-year ...

The sharp 250 basis points quarter-on-quarter decline in gross margin (the third consecutive sequential fall) reinforces ...

The senator says he is all about economic development for North Louisiana and wants to build on assets. He says the facility ...

Thank you for joining us today for the Dr. Reddy's earnings conference call covering the quarter and full year ended March 31, 2025. We appreciate your time and participation. Joining us today is the ...

The company reported a 22% year-on-year rise in consolidated net profit, reaching Rs 1,594 crore, surpassing analysts' ...